Considering these results, FNDC5 probably plays the role of a critical mediator in the pathology of Alzheimer’s disease; however, the exact mechanism of how FNDC5 affects APP metabolism has not been referred yet. This evidence concerns the gene FNDC5 and early-onset autosomal dominant Alzheimer disease.